City

Houston (1)

Portland (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

OHSU Knight Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (1)

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Intervention

doxorubicin hydrochloride (1)

laboratory biomarker analysis (1)

pharmacological study (1)

ribociclib (1)

sintilimab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

locally advanced undifferentiated pleomorphic sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting

Advanced Soft Tissue Sarcoma
+26 more

Doxorubicin Hydrochloride
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Jan 6, 2023

Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

Recruiting

Locally Advanced Undifferentiated Pleomorphic Sarcoma
+3 more

Sintilimab

Houston, Texas

M D Anderson Cancer Center

Jul 31, 2022